Eye News and Research

Latest Eye News and Research

Bacteria multiply and grow into biofilms like settlers form cities

Microbiologists have long adopted the language of human settlement to describe how bacteria live and grow: They "invade" and "colonize." Relations dwelling in close proximity are "colonies."

13 Mar 2020

Nanoscale particles of common plastics tend to move through the water supply

A Washington State University research team has found that nanoscale particles of the most commonly used plastics tend to move through the water supply, especially in fresh water, or settle out in wastewater treatment plants, where they end up as sludge, in landfills, and often as fertilizer.

13 Mar 2020

UC Riverside biochemist and Atomwise form new joint venture

Over the past few years, biochemist John Jefferson Perry at the University of California, Riverside, has collaborated on a number of projects with Atomwise Inc., a company that uses artificial intelligence, or AI, for drug discovery.

13 Mar 2020

Tooth-enamel protein discovered in the eyes of people with dry AMD

A protein that normally deposits mineralized calcium in tooth enamel may also be responsible for calcium deposits in the back of the eye in people with dry age-related macular degeneration, according to a study from researchers at the National Eye Institute.

13 Mar 2020

Study provides better understanding of relationship between hearing loss and risk for falls

What people hear and do not hear can have a direct effect on their balance, according to new research from the New York Eye and Ear Infirmary of Mount Sinai.

12 Mar 2020

Fight for Sight funded researcher develops gene therapy approach for glaucoma

A Fight for Sight funded researcher from the University of Bristol has used gene editing techniques to successfully demonstrate a gene therapy for glaucoma in the lab, in results published in Molecular Therapy in March.

11 Mar 2020

Cream infused with microscopic STAR particles could facilitate better treatment of skin diseases

Skin diseases affect half of the world's population, but many treatments are not effective, require frequent injections, or cause significant side effects.

10 Mar 2020

Abnormal retinal gene function underlying vision loss in dogs

A canine study carried out at the University of Helsinki has described a gene variant in the regulatory region of the retina resulting in the abnormal function of retinal genes and, eventually, in the loss of vision in dogs.

10 Mar 2020

Baylor College of Medicine and UH team up for new research collaborations

Baylor College of Medicine and the University of Houston are teaming up for new research collaborations.

10 Mar 2020

Music appears to decrease delirium in critically ill patients

It is common for critically ill patients on life support to develop delirium, a form of acute brain failure for which no effective treatment is known.

10 Mar 2020

Modern virtual and augmented reality device can be used to simulate visual impairments

Published today, during World Glaucoma Week 2020, a new study demonstrates how commercially available head mounted displays can be used to simulate the day-to-day challenges faced by people with glaucoma.

10 Mar 2020

Marinomed extends the range of Marinosolv applications

Marinomed Biotech AG has achieved promising results for further areas of application with its Marinosolv® technology platform in preclinical studies.

From Marinomed Biotech AG 10 Mar 2020

'Primitive' stem cells shown to replace and repair damaged blood vessels in the retina

Johns Hopkins Medicine scientists say they have successfully turned back the biological hands of time, coaxing adult human cells in the laboratory to revert to a primitive state, and unlocking their potential to replace and repair damage to blood vessels in the retina caused by diabetes.

9 Mar 2020

Two retinal imaging modalities cannot be interchanged when evaluating vision-threatening condition

Diabetic retinopathy can be diagnosed and graded with the use of a newer scanning technology called ultra-wide field imaging, a system that generates high-quality pictures showing most of the retina.

5 Mar 2020

During a pandemic, states’ patchwork of crisis plans could mean uneven care

A possible coronavirus pandemic could overwhelm the nation's hospitals and force doctors into difficult decisions about how to allocate limited resources. Yet, experts say, only a handful of states have done the work necessary to prepare for such worst-case scenarios.

5 Mar 2020

Eye movements play functional role in memory retrieval, study shows

In a recent study, scientists at Baycrest's Rotman Research Institute (RRI) found that research participants moved their eyes to determine whether they had seen an image before, and that their eye movement patterns could predict mistakes in memory.

5 Mar 2020

MIT scientists produce a new model of vision

When we open our eyes, we immediately see our surroundings in great detail. How the brain is able to form these richly detailed representations of the world so quickly is one of the biggest unsolved puzzles in the study of vision.

5 Mar 2020

Smartphone users have more headaches, find less relief from the medication

A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.

4 Mar 2020

AI may help identify newborns at risk for aggressive posterior retinopathy of prematurity

An artificial intelligence device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity.

4 Mar 2020

Preclinical data of Ocugen's OCU400 genetic modifier published in Nature Gene Therapy

Ocugen, Inc., a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, announced today the publication in Nature Gene Therapy of preclinical data of nuclear hormone receptor gene NR2E3 as a genetic modifier and therapeutic agent to treat multiple retinal degenerative diseases.

3 Mar 2020